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Factors Influencing Breast Cancer Genetic Testing Among High Risk African American Women: A
Systematic Review
African American women are disproportionately impacted by breast cancer and its associated effects. They have
the highest breast cancer mortality rate of all racial and ethnic groups in the U.S., yet, many high risk African
American women do not follow-up with genetic testing despite, having a shorter survival rate and more likely to
develop malignancies or aggressive forms of breast cancer than white women. Purpose: This review explored
breast cancer genetic follow up and barriers among African American women and made recommendations for
designing tailored high risk breast cancer programs. Method: The Integrative Model of Behavioral Prediction
framework provided the framework for the review. PubMed, PSYINFO, CINAHL and Cochrane Collection
Plus databases were searched for articles published from 2007 to 2017 that focused on attitude and beliefs that
influenced genetic testing follow up among African American women. Three reviewers independently reviewed
and appraised articles. The quality of the articles was assessed to determine the evidence level and overall
recommendations using the Joanna Bridge Institute grading criteria. Results: Sixteen of the 2275 articles
reviewed met the inclusion criteria of which, seven showed statistically significance changes related to family
concerns, medical mistrust and cost barriers; decreases in breast cancer worry and perceived risk after genetic
counseling; and higher education level and diagnosed early increased genetic testing. Conclusions: This
systematic review provides greater understanding of how the social determinants of health influence decisions
about genetic testing and treatment to determine why African American women who are at risk for breast
cancer, do not progress to genetic testing. It provided recommendations for designing sensitive curriculum
content for African American women and providers to increase genetic follow-up and reduce breast cancer
disparity. The results of this review could be used to design comprehensive, tailored interventions to address
the identified barriers, increase breast cancer awareness and early detection, and help minority women make
informed, value decisions about genetic testing and treatment options. Recommendations: Future research is
required to examine the role communities, agencies and policy makers play in improving clinical outcomes for
minorities.
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Background: African American women are disproportionately impacted by breast cancer and its associated effects.  They have 
the highest breast cancer mortality rate of all racial and ethnic groups in the U.S., yet, many high risk African American women do 
not follow-up with genetic testing despite having a shorter survival rate and being more likely to develop malignancies or aggressive 
forms of breast cancer than White women.  Purpose: This review explored breast cancer genetic follow up and barriers among 
African American women and made recommendations for designing tailored high risk breast cancer programs. Method: The 
Integrative Model of Behavioral Prediction framework provided the framework for the review. PubMed, PSYINFO, CINAHL and 
Cochrane Collection Plus databases were searched for articles published from 2007 to 2017 that focused on attitude and beliefs 
that influenced genetic testing follow up among African American women. Three reviewers independently reviewed and appraised 
articles. The quality of the articles was assessed to determine the evidence level and overall recommendations using the Joanna 
Briggs Institute grading criteria.  Results: Sixteen of the 2275 articles reviewed met the inclusion criteria, of which seven showed 
statistically significant changes related to family concerns, medical mistrust, and cost barriers; decreases in breast cancer worry 
and perceived risk after genetic counseling; and higher education level and diagnosed early increased genetic testing.  
Conclusions: This systematic review provides greater understanding of how the social determinants of health influence decisions 
about genetic testing and treatment to determine why African American women who are at risk for breast cancer do not progress 
to genetic testing. It provided recommendations for designing sensitive curriculum content for African American women and 
providers to increase genetic follow-up and reduce breast cancer disparity.  The results of this review could be used to design 
comprehensive, tailored interventions to address the identified barriers, increase breast cancer awareness and early detection, 
and help minority women make informed, value decisions about genetic testing and treatment options.  Recommendations: Future 
research is required to examine the role communities, agencies, and policy makers play in improving clinical outcomes for 
minorities. 
Keywords: breast cancer, genetic test, African American women, barriers, attitude/beliefs, social determinants of health 
FACTORS INFLUENCING BREAST CANCER GENETIC TESTING AMONG AFRICAN AMERICAN WOMEN 1 
 
 
© The Internet Journal of Allied Health Sciences and Practice, 2019 
 
INTRODUCTION 
In the United States, breast cancer is the most common cancer among women of all races/ethnicities and the second leading 
cause of cancer deaths.1 Although more White women (WW) are diagnosed with breast cancer, African American women (AAW) 
are disproportionately impacted by breast cancer and its associated effects. They have the highest breast cancer mortality rate of 
all racial and ethnic groups, have a higher occurrence of breast cancer before age 50, are diagnosed later, have a shorter survival 
rate, are affected by earlier-onset and aggressive, are difficult to treat triple-negative breast cancer (TNBC), and are more likely to 
have malignant genetic variants than WW.2-4   
Early detection and prompt treatment have been demonstrated to reduce breast cancer mortality and extend or improve quality of 
life.5 However, many AAW with breast cancer miss opportunities for early interventions. Underutilization and irregular utilization of 
breast cancer screening among AAW may contribute to the disparities in survival and mortality rates.6,7 This reduced adherence 
to breast cancer screening guidelines leads to later stage cancer diagnoses in AAW, a factor correlated with lower survival rates.8,9  
Even a three-month treatment delay can contribute to breast cancer mortality.10  One study reported only 64% of AAW aged 40 
years and over adhere to recommendations for annual clinical breast examination; even fewer (50%) reported adhering to the most 
effective early detection, risk reducing, and clinical management strategies.5  
An estimated 5%–10% of breast cancers are hereditary, and primarily attributed to BRCA1 or BRCA2 gene mutations.1 Although 
the population of AAW who have these gene mutations is low, risk assessment through genetic counseling and testing is vital.  It 
provides the opportunity to gain early access to preventative and specialized care and provides them with information to make 
valued informed health care decisions.  Women with a personal history of breast cancer have a 55%-85% lifetime risk. Women 
with BRCA1 or BRCA2 mutation have a distinctly increased risk for the disease, especially for women age 40 and younger.11,12 
Furthermore, women with a BRCA1 mutation have a lifetime risk as low as 31%.2,13 The prevalence of the disease increases as 
the mutated gene is passed on to their children.   
Social Determinants of Health (SDOH) 
The SDOH-economic stability, health literacy/education, social and community context, healthcare system, and neighborhood and 
built environments play a key role in the uptake of genetic testing.6,14  Approximately 85% of all breast cancer is nonhereditary and 
associated with the SDOH.2,3,15  Although there is a critical need to conduct more genetic testing among AAW diagnosed with 
breast cancer, evidence suggests that many high-risk AAW do not follow-up with testing because of barriers related to the SDOH.16  
Barriers such as limited health literacy and psychological distress associated with inability to understand genetic information, 
access to healthcare services, ineffective communication, attitude and cultural beliefs, family, and socioeconomic status may 
explain why AAW are hesitant to follow-up.5  One study suggests that AAW with breast cancer are 78% less likely to undergo 
genetic screening and testing as compared to WW with comparable histories because of socioeconomic factors, risk perception, 
attitudes, or primary care physician recommendations.17  
 
Although numerous studies support the benefits of genetic screening and testing for breast cancer genetic variants, little is known 
about AAW’s attitudes or recent experiences with genetic testing, why many do not progress to testing, or why interventions to 
increase genetic testing have been implemented, but with little progress.1,10 The aim of this systematic review is to synthesize 
current evidence exploring breast cancer genetic testing follow up and barriers from the perspective of AAW and make 
recommendations to consider when designing tailored high-risk breast cancer programs. 
 
Theoretical Framework 
The Integrative Model of Behavioral Prediction (IMBP) framework provided the framework for the review.  This model postulates 
that intentions are the strongest predictor of behavior, and individuals will act on them when they have the essential skills and 
environmental constraints do not impede behavioral performance.18  The intentions are formed by the interactions of perceived 
social norm, attitude and self-efficacy. The association between background factors and behavior depicts the flexibility and 
adaptability of the model to varied cultures, contexts, and diverse populations. 
 
According to the IMBP, the intention to pursue genetic screening and testing can be influenced by attitudes, beliefs about social 
norms, and control beliefs (self-efficacy).  Also, the IMBP evaluates the effects of barriers that may influence an individual’s decision 
to progress to genetic screening and testing. The model provides opportunities for tailored educational intervention to help women 
diagnosed with breast cancer understand genetic screening and testing, improve the accuracy of risk perception, and address 
psychosocial aspects and information to facilitate informed health care decisions. 
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METHODS 
The systematic approach, consisting of input-searching the literature, throughput- processing the literature, and output– writing the 
review was employed. A combination of quantitative and qualitative reviews is included to develop a deeper understanding of the 
socio-psychological and experiential phenomenon of why AAW diagnosed with breast cancer do not follow-up with genetic testing.  
 
Search Strategy 
The search was conducted using PubMed, CINAHL, PSYINFO, and Cochrane Collection Plus strategies using a combination of 
the following subject headings and keywords: “breast cancer barriers” AND “genetic testing,” “breast cancer genetic testing AND 
“AAW barriers,” and “breast cancer genetic testing” AND “African Americans’ attitudes.”  The search was limited to English 
language articles from 2007 to 2017. Studies published prior to the year 2007 were excluded because they were not reflective of 
the existing breast mortality and survival rates, advanced treatments, and progress.  The search was designed to retrieve various 
subtopics within the main topic, including beliefs and perceptions.   
Study Selection 
Three authors conducted the search, coded the studies, and independently reviewed the coded studies. Disagreements among 
the coders and the reviewers were discussed until agreement was reached among all authors.  We conducted a three-stage 
screening process beginning with a title review, abstract review, and full text article review to determine eligibility. 
 
Data Abstraction and Tabulation 
Articles details were abstracted using data abstraction forms to collect data and create reports on the year of publication, study 
design, sample size, population, focus, measures, grading quality, and recommendations.  
 
Quality Assessment and Grading 
The process of the grading of evidence is depicted in Table 1.  The validity of the articles selected for the review was assessed 
using a modified Joanna Briggs Institute (JBI) grading of evidence level for effectiveness and meaning.19 Quantitative studies were 
assessed and rated according to five levels of effectiveness, and qualitative studies were rated according to five levels of 
meaningfulness.  Quantitative studies were assessed and rated according to five levels of effectiveness, with level one - 
experimental design, representing the strongest evidence and level 5-expert opinion and bench research, representing the weakest 
evidence.  Qualitative studies were rated according to five levels of meaningfulness, with level 1-qualitative or mixed methods 
systematic reviews and level 5-expert opinion, representing the least meaningfulness 
 
Table 1. JBI Level of Evidence Scales for Effectiveness and Meaningfulness  
Levels of Evidence 
Effectiveness 
Level 1: Experimental design                                                                                                                                              
Levels 2: Quasi-experimental design,                                                                                                                              
Levels 3: Observational,-analytic design                                                                                                                     
Levels 4: Observational,-descriptive design                                                                                                              
Levels 5: Expert opinion and bench research 
Meaningfulness 
Level 1: Qualitative or mixed methods systematic reviews                                                                                           
Level 2: Qualitative or mixed methods synthesis                                                                                                            
Level 3: Single qualitative study                                                                                                                                     
Level 4 Systematic review of expert opinion                                                                                                                       
Level 5: Expert opinion 
Adapted with permission The Joanna Briggs Institute Levels of Evidence and Grades of Recommendation.19 
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The JBI Grades of Recommendations were used to integrate the best available evidence on breast cancer genetic test follow up 
and barriers from the perspective of AAW and make evidence-based recommendations for designing tailored risk breast cancer 
programs (See Table 2). The JBI has two grades for recommendations: Grade A is a strong recommendation and Grade B is a 
weak recommendation.19 All studies are evaluated using the FAME (feasibility, appropriateness, meaningfulness, and 
effectiveness) scale developed by the JBI.19   
 
Table 2. Grades of Recommendation                                                                                                                                                      
Grade Definition 
A ‘Strong’ recommendation. (1) Desirable effects outweigh undesirable effects of the health management strategy; 
(2) evidence of adequate quality supporting its use; (3) there is a benefit or no impact on resource use, and (4) 
values, preferences and the patient experience have been taken into account. 
B  ‘Weak’ recommendation (1) desirable effects appear to outweigh undesirable effects of the health management 
strategy, though not clear; (2) evidence supporting its use, even though this may not be of high quality; (3) there 
is a benefit, no or minimal impact on resource use, and (4) values, preferences and the patient experience may or 
may not have been taken into account. 




The search identified 2275 distinctive articles.  The title and abstract screens were retained. Of these, 86 articles were selected for 
further consideration, and 2163 articles were removed after accounting for duplication or did not include breast cancer genetic test 
or classify race/ethnicity.  Of the remaining 30 articles, 14 articles did not include barriers to breast cancer genetic test, African 
American beliefs, attitudes, or perceptions or meet the African American 10% minimum sampling requirement. Full text screening 
with reference list searching identified 16 articles that met the target criteria. The article selection process is depicted in Figure 1.  
Articles included in the review met the study inclusion and exclusion criteria (See Table 3). 
 
Table 3. Study Inclusion and Exclusion Criteria                                                                                                                                                                          
Inclusion Criteria Exclusion Criteria 
1. Studies in English 1. Studies not in English 
2. Peer reviewed studies 2. Studies more than 10 years old 
3. Studies published from 2007-2017 3. Studies not in the United States 
4. Studies included African American women  4. Race/ethnicity is not classified  
5.African American women represented at least 10%  of 
sample 
5. African American women participants were < 10% of 
sample 
6. Examined or explored attitudes, perceptions, beliefs or 
barriers related to genetic testing 
6.  Contained commentaries or discussions on the subject 
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Figure 1.  PRISMA flowchart of eligible studies20 
 
Characteristics of the Study Samples 
Characteristics identified and summary of review are presented in Table 4 (see Appendix A).  Sixteen quantitative and qualitative 
studies comprised this review.  Twenty-five percent of the studies collected data using qualitative designs, 25% used cross 
sectional designs, 12% used secondary analysis, 6% used randomized trial design, 6% used retrospective design, 6% used 
systematic review design, 6% used integrative review design, 6% used prospective analysis design, and 6% used a descriptive 
design.  Of these studies, eleven studies included samples comprised of AAW, two included 18% or less AAW, one study included 
24%, one study included 26%, and another included 65%.  Ten studies included all adults, one study classified the sample as 
below age 50, one study classified the sample as age 20-69, one study classified the sample as mean age 52, one study classified 
the sample as age 25-49, one study classified the sample as age 20-45, and one study classified the sample as age 21 and older.  
The most common outcomes in the studies reviewed were breast cancer-related beliefs, attitudes and perceptions (psychosocial,), 
knowledge and perceived risk (cognitive), and health care system. 
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Beliefs, Attitudes, and Perceptions (psychosocial factors) 
Most of the women reported interest in genetic testing and associated breast cancer-related beliefs, attitudes, or perceptions with 
knowledge and perceived risk as primary outcomes.  Benefits to genetic screening and testing included providing education to 
raise breast cancer awareness, information to prevent breast cancer, and information to make informed decisions (18%). Two out 
of sixteen articles (12%) cited physician recommendation as motivators to progress to genetic testing.  The four studies that 
assessed religion and spirituality reported a possible association with coping, hope, and genetic follow up. 
 
Knowledge and Perceived Risk (cognitive)  
Lack of knowledge of breast cancer and risk factors were negatively associated with genetic testing follow up. Half of the studies 
reported low and inaccurate breast cancer knowledge among AAW.  One study suggested that minority women have low levels of 
genetic testing awareness, and this influenced their decision to progress to genetic counseling/genetic testing.  Another study 
explored misunderstanding about genetic tests.  Most participants lacked knowledge about genetic tests and believed the tests 
are more predictive than they actually are.  Only one study reported no clear association between feeling susceptible to getting 
breast cancer and the likelihood of being in a group that received or did not receive breast cancer genetic counseling.    
Barriers 
A summary of barriers is presented in Table 5.  All studies assessed the healthcare system and reported barriers to genetic testing 
follow up and treatment.  Barriers identified from the review are classified according to the SDOH.  These barriers experienced by 
AAW were associated with economic stability, education, social and community context, the health care system, and neighborhood 
and built environments.  The economic stability determinant focused on employment and income including constraints beyond the 
individual’s ability to pay for services and work conflict.  Education focused on health literacy and education level including lack of 
knowledge about genetic counseling/testing, perceived risk, testing process/procedures/effects, risk management, and results.  
These factors limited individuals’ ability to make informed health care and treatment decisions.  The most common barriers in the 
studies reviewed were related to social and community context (psychosocial), health care system, and education (cognitive), 
respectively.  
 
Social and Community Context (psychosocial,) 
The influence of social factors on an individual’s belief or behavior were the most commonly cited barriers.  Fourteen out of sixteen 
(87%) of the articles cited social barriers.  Family concerns (50%) followed by fear or worry of positive breast cancer results (43%), 
discrimination related to employment, healthcare system or denied health coverage due to pre-existing conditions (37%), medical 
mistrust (31%), and stigmatization due to breast cancer status (31%) were the most common social barriers.  Other barriers 
included lack of privacy (18%), shame of being a burden to society (12%), fatalism, powerless to control the onset and progression 
of cancer (12%), nonscientific beliefs (6%), and disinterest (6%). 
 
Healthcare System 
The healthcare system barriers focused on health care coverage, provider knowledge, and access to quality or specialized services 
including community counseling services.  Health care coverage was the most cited health care barrier.  Ten out of sixteen (62%) 
of the articles cited financial concerns regarding lack of insurance coverage or out of pocket costs.  Provider barriers focused on 
lack of referrals (31%), lack of effective referral system to track AAW’s referral progress (6%), lack of knowledge of genetic services 
(6%), lack of genetic testing with clinical guidelines for cancer susceptibility (6%), and limited time to counsel (6%).  Other health 
care concerns included lack of access to quality or specialized services (6%) and limited number of community counseling services 
(6%).    
 
Education 
Lack of knowledge was the most cited health literacy barrier.  Eight out of sixteen (50%) of the articles cited lack of knowledge 
about perceived risks, genetic testing process/procedures, risk management results, side effects associated with genetic testing, 
and having difficulty making health care decisions about genetic testing and selecting treatment options as barriers. Only one 
article (6%) cited language as a barrier.        
 
Economic Stability and Neighborhood and Built Environments 
Four out of sixteen articles (25%) cited income related to constraints beyond an individual’s ability to pay for services including 
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bills, support  
Constraints beyond individual’s 
ability to pay for services  
4(25%) 
 
Adams et al,29 Hayden et al,33 
Jones et al,13 and Ramirez et 
al36 
Education  Language Health 
literacy/ Education 
level 
Lack of knowledge:                           
Perceived risk, testing process, 
procedures; risk-management, 
results; decision making; side 
effects associated with testing 
8(50%) Jones et al,11 Adams et al,29 
Sheppard et al,17 Glenn et al,31 
Klitzman34, Susswein et al,24 





















healthcare system, preexisting 
condition, race 
Stigmatization due to breast 
cancer status  
                                                       
Family concerns: Ineffective 
communication, lack of 
awareness of family history, 
medical condition and hereditary 
effects, medical  




















Adams et al,29 Sheppard et 
al,17 Glenn et al,31 Susswein et 
al,24 and Sheppard et al37 
Ford et al,30 Sheppard et al,17 
Sussner et al,39 Sussner et al,40 
and Sherman et al38 
Jones et al,13, Sheppard et al,17 
Glenn et al,31 Susswein et al,24  
Sherman et al,38 Sussner et 
al,39 Sussner et al,40 and 
Ramirez et al36 
Adams et al,29 Sheppard et 
al,17 Glenn et al,31 Sheppard et 
al,37 and Sussner et.al40 
Sussner et al,39 S Sussner et 
al,40 and Sherman et al38 
Adams et al,29 Sheppard et 
al,17 Ford et al,30 Halbert et al,32 
Sussner et al,40 , Sherman et 










Providers: Lack of genetic 
knowledge /services and clinical 
guidelines for testing and 
referrals, ineffective referral 
system, limited counseling 
Cost, lack of insurance coverage, 
or out of pocket costs, inability to 





Jones et al,13 Klitzman,34 
Sheppard et al,37 Sheppard et 
al,17 and Susswein et al24 
 
Jones et al,11 Adams et al,29 
Jones et al,13 Sheppard et al,17 
Glenn et al,31 Ford et al,30 
Susswein et al,24 Sherman et 
al,38 Ramirez et al,36 and 
Hayden et al33 
Barriers identified in 18% or more studies                                                                                                                                            
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DISCUSSION 
Evidence from the review suggests the SDOH collectively, influences genetic follow up and how healthcare decision are made 
among AAW.  Social contexts and community engagement, the healthcare system, and health literacy are identified as key 
problematic areas and warrant consideration. 
 
Social and Community Context  
Social and community context factors have the greatest influence on AAW’s genetic testing follow up and how they make decisions. 
Family concerns have the greatest influence followed by fear/worry about cancer, discrimination related to employment, the 
healthcare system or healthcare coverage due to breast cancer status, medical mistrust, and stigmatization respectively.  Family 
concerns were related to AAW’s inability to discuss their breast cancer conditions because they do not fully understand their breast 
cancer conditions and how it impact their families.  The main concerns are ineffective communication, lack of awareness of family 
history, effects of medical condition, and heredity. 
 
The few published studies exploring medical mistrust demonstrated significant associations with perceived advantages and 
disadvantages of genetic testing, as well as medical mistrust among African Americans. The findings revealed how social and 
cultural beliefs foster AAW’s misunderstandings about genetic testing elicit medical mistrust, an important predictor of health 
behaviors in AAW.   The most common reasons for medical mistrust are fear that medical institutions would use genetic test results 
exclusively for beneficial reasons, privacy concerns, and loss of medical coverage or employment if their breast cancer status is 
identified. These beliefs are closely associated with employment, the healthcare system, or healthcare coverage discrimination.  
The misunderstandings highlight the need to dispel myths about breast cancer genetic testing.   
Spiritual/religious Beliefs  
Several studies (25%) explored AAW’s spiritual/religious cultural beliefs to some degree.  Overall, AAW’s attitudes about breast 
cancer and genetic testing, are associated with their spiritual/religious beliefs.  One study suggests the use of spiritual coping has 
been associated with a perception of lower breast cancer risk.21 More work is needed in this area to fully understand 
spirituality/religious effects.    
 
Community Engagement 
Approaches to address breast cancer health inequality should be addressed at both the individual and community levels. A 
Community Partnership Program with local organizations to work in medically African American communities may promote targeted 
breast cancer prevention strategies, increase breast cancer genetic testing awareness, and reduce outcome disparities. 
Furthermore, the partnership may provide increased sponsorship and support to apply tailored strategies and resources to increase 
African Americans’ community engagement.    
 
The Healthcare System 
In the healthcare system, insurance coverage and out of pocket costs continue to be primary barriers to genetic testing, followed 
by lack of provider genetic knowledge for AAW at risk for breast cancer and ineffective referral tracking systems.  The existing data 
suggests the cost concerns expressed by the AAW are associated with their socioeconomic status.  African Americans have the 
lowest median household income among White, Asian and Latino households in the U.S.22 Although the median household income 
rose to $57,617 in 2016, for African Americans, it was $38,555, the lowest of all racial groups.22 Moreover, 22% of African American 
households live in poverty, and African Americans’ unemployment rate almost doubles the rate of Whites.22 One study showed 
affordability and insurance coverage as key reasons for non-genetic test follow up.23  
 
Seeking additional funding opportunities such as community partnership may mitigate costs.  Currently, public policies such as the 
Affordable Care Act, provide access to healthcare services for genetic screening and preventative services for high risk women.  
Community partnerships with health insurance agencies and health care organizations to lower health care costs may increase 
AAW’s access to genetic screening and treatment.  Nonetheless, factors influencing AAW’s access to care should continue to be 
examined to discover the association between cost and other sociocultural factors.  One study showed that African Americans 
were less likely than Whites to pursue BRCA1/2 genetic testing, even when barriers of cost and access were minimized.24 
 
Referral System 
Some high risk AAW who are eligible for genetic testing are not referred; this contributed to a paucity of provider referrals and 
inadequate referral tracking systems to track the progression from initial identification and referral for genetic counseling/testing to 
genetic specialists and oncologists. One study revealed 5 of 11 women with a history of bilateral breast cancer and carry a BRCA1⁄ 
2 mutation were not referred for risk assessment at the time of diagnosis, and could have been recommended to reduce the risk 
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of developing a second breast cancer.25   More efforts are needed to address this issue because AAW are predisposed to a more 
aggressive form of breast cancer at an earlier age than the general population.   
 
Provider Training 
African American women have high trust in their personal providers and their recommendations for genetic testing.  Other studies 
produced similar findings.26,27 Yet, existing evidence suggests providers may not be culturally competent enough to address AAW’s 
psychosocial needs, including the need for genetic and specialized services.  Cultural competency is key to comprehending how 
AAW’s attitudes and beliefs, impact their health, and consequently, improve patient-provider relations. The majority of genetic 
services providers (91%) and counselors in the U.S., are White, from a different ethnic group and may not understand AAW’s 
needs.25  
 
One study surveyed 220 internists about their genetic utilizations; findings showed most rated their knowledge as very/somewhat 
poor concerning geneticists/genetic counselors, types of tests to order, counseling patients, interpreting results and maintaining 
privacy.28 Providers may not know how to identify and treat high risk patients or make appropriate referrals. Several studies suggest 
physicians with poorer understanding of breast cancer genetics recommend genetic services less frequently.25 Increasing culturally 
competent, knowledgeable providers may improve patient-provider relationships, build trust and provide AAW with the information 
to make informed, valued decisions.  
 
Health Literacy/Education 
Fifty percent of the studies identified culturally tailored education for AAW and their families as key to increasing genetic breast 
cancer awareness and early detection, mitigating misconceptions about genetic testing, improving informed valued decisions about 
genetic testing and treatment options, and improving clinical outcomes.  Recurring themes focused on helping AAW understand 
the advantages and disadvantages to genetic testing, how to make use of the genetic test results for themselves and their families, 
how breast cancer impacts their health behaviors and lifestyle choices, and how to reduce their risk of dying from breast cancer.  
Furthermore, evidence suggests that forums to discuss the roles of spiritual and religious values, beliefs and attitudes, and family 
or friends influence on the decision-making process may improve the accuracy of their risk perceptions. 
 
RECOMMENDATIONS 
The existing evidence suggests a multi-faceted approach should be taken to address the multidimensional nature of breast cancer 
disparity among AAW.  Their families are key motivators to genetic follow up and should be included.  Furthermore, AAW make 
decisions based on family values, and genetic follow up is associated with understanding more about their families’ breast cancer 
risk. A comprehensive, tailored genetic breast cancer education and outreach screening intervention is needed, as African 
Americans and other minorities trail behind in the utilization of genetic services to reduce breast cancer mortality rates, improve 
survival rates, and health and quality of life. Table 6 summarizes the recommendations. Three major categories of 
recommendations in the reviewed studies are relevant to addressing barriers to genetic follow up and treatment. These categories 
are associated with the SDOH and include biologic and psychosocial topics related to health literacy, social and community context, 
and the healthcare system. They should be considered when developing tailored breast cancer risk program content for AAW.   
 
LIMITATIONS 
This review has several limitations. The review explores barriers and why AAW do not progress to genetic testing. As a result, 
most of the studies are descriptive and cross-sectional in nature and do not allow for determination of cause and effect relationships 
in the observed associations.  Other limitations include self-reported data regarding the use of genetic services, some samples are 
not reflective of AAW with less education or low income, some studies have small sample sizes, some underrepresent younger 
AAW, and others are limited to those published in the U.S.  Furthermore, there is limited experimental data on why AAW do not 
progress to genetic testing, and some results are not generalizable to other populations. Despite these limitations, the results are 
meaningful.  Studies included a diverse set of AAW from different regions of the U.S. but still produced similar findings. 
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Rationale: Improve patient-provider relationship. Develop culturally competent providers and increase their 
genetic utilization and increase African American women’s breast cancer genetic  
awareness.11,13,23,27, 29-31,36,39 
 
Primary care provider training  
  Cultural competency (include unique cultural beliefs of minorities) 
  Exploration of unconscious biases  
  Identification of breast cancer support services and how to refer   
  Utilization of breast cancer genetic testing clinical guidelines, include ordering and interpreting genetic 
  results and genetic privacy 
  Utilization of a standardized risk assessment tool 
 
African American women and family education  
  Breast cancer awareness 
  Family history 
  Breast cancer genetics: counseling/testing: process/procedure, benefits, advantages and 
  disadvantages, risks, reliability of test results 
  Medication side effects 
  Psychosocial exploration: trust related to data usage, breast cancer worry/fear  
  Stigmatization and perceptions 
  Cultural exploration of spiritual and religious values, decision-making with decision-making aids 






Rationale: Improve access to quality or specialized services to increase early detection, diagnosis and 
treatment.11,13,17,23,24,29-31,33,36,38 
 
Establish an effective referral tracking system to track progress: 
  Utilization of electronic record system 
  Standardized family history data collection forms to identify high risk individuals  
  Available genetic services within settings that provide healthcare services to large  
  numbers of AAW  
 
Risk assessment 
  Conduct breast cancer risk assessment screening during annual,/primary care or  
  gynecologic visits 
  Target younger AAW at increased risk for breast cancer 
 






Rationale: Promote community engagement to increase access to effective care and treatment.24,29,37,38 
  
 Establish community level breast cancer education and risk assessment  
  Support outreach efforts to groups that provide information and support to younger breast cancer victims 
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IMPLICATIONS FOR PRACTICE AND/OR POLICY  
These findings have decisive implications for medical practice, education, community leaders, and policy makers.  Although AAW 
who are at increased risk may report positive interests about genetic testing, few elect to follow-up with genetic testing.  The limited 
number of studies that have evaluated genetic test acceptance in this population, suggest that barriers to participation in genetic 
counseling/testing, continues to exist.  Furthermore, few interventions have been designed to fully address the multifaceted nature 
of AAW who are at high risk for breast cancer nor developed comprehensive interventions that address the influence of multiple 
SDOH that present as barriers for many minority women. Many of the barriers that are addressed in this review are the unresolved 
barriers that existed over 15 years ago, indicating the need to develop educational interventions as adjuncts to genetic 
screening/testing and increase access to effective care and community engagement.   
 
The results of this review could be used to design comprehensive, tailored interventions to address the identified barriers, increase 
breast cancer awareness and early detection, and help minority women make informed, value decisions about genetic testing and 
treatment options.  Given the breast cancer impact on women, as well as nationally and premature deaths rates, efforts should 
continue to increase access to effective care and treatment, especially in underserved communities. 
  
Future studies are needed to examine methods to increase community engagement and its impact on breast cancer awareness 
and decreasing the mortality rate; assess provider education for those who do not specialize in breast cancer; examine how race 
and cultural identity influence beliefs about genetic testing, explore emotional and psychosocial factors related to genetic follow 
up, and identify factors influencing the decision-making process.   We recommend using larger sample sizes reflective of a diverse 
African American population and include more AAW who are younger and at high risk, have low income and education level, and 
are uninsured/underinsured. 
CONCLUSIONS 
This systematic review is one of the few reviews to synthesize current published literature focused on the social determinants of 
health (SDOH) factors collectively, influencing breast cancer genetic follow up from the perspective of AAW who are at risk for 
breast cancer, to determine why they do not progress to genetic testing. It provides greater understanding of how SDOH, especially 
cultural beliefs and attitudes about breast cancer, influence decisions about genetic testing and treatment.  Furthermore, the review 
includes recommendations for designing tailored breast cancer risk programs for AAW to reduce breast cancer disparity.  The 
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(U.S. region, age) 
Focus 
 












N = 50 
 
East, AAW, ≥21  Assessed 
knowledge and 





88% never heard of BRCA1/2, 54% 
aware of GT, 94% GT interest  
Motivators: physician 
recommendation, health awareness 









N = 20  
 





cultural beliefs of 







social support and 
programmatic 
factors 
All groups associated “breast cancer” 
with fear; 
AAW who did not receive GC were 
most knowledgeable; WW who did not 
receive GC; reported uncertainty and 











N = 33  
 
West, White, Asian, 
Latino and African 
American survivors or 
first-degree relatives of 





GT follow-up  
Factors influencing 
genetic follow-up 
Low levels of awareness observed in 
minority women, beliefs influenced 
decisions about treatment options, 
mistrust of genetic information. 
3 A 
Halbert 








N = 176  
 
East, AAW, adults Evaluated the 
effects of GC/GT 
based on different 
levels of exposure  
Evaluated cancer 
perceived risk and 
cancer worry 
Counseling participants reported 
perceived risk compared to non-
participants, test result acceptors 
reported decreases in cancer worry, 
having a cancer history associated 
with increases in cancer worry 
2 A 
Hayden 








African American and 
White adults  
Analyzed reasons 





barriers to GT 
51.4% did not pursue GT following 
GC-not indicated, 22.5%-cost 
concerns, 17.1%-disinterest   
3 A 
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services 
Younger AAW are not referred for 
GT when appropriate and 


















family support and 
perceived control 
Significantly, less AAW-reported 
having GC and GT  
compared with WW/others, 
Income associated positively with 
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Higher education levels 








N = 32  
 
AAs, Whites, Asians, 
Hispanics with breast 
cancer, age 20-69 
Explored 
misunderstandings 
about GT  
Factors influencing 
GT  
Most common-lack of 
understanding about GT  
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Women with advanced degrees 
are most informed about BRCA 
GT, More WW knew about breast 
cancer genetics than other groups  
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providers’ recommendations, 




et al37  
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sectional 
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increased risk for 












discrimination and  
engagement 
Reported interest in GC/GT does 
not translate into actual GC/GT 
engagement 





FACTORS INFLUENCING BREAST CANCER GENETIC TESTING AMONG AFRICAN AMERICAN WOMEN 15 
 
 
© The Internet Journal of Allied Health Sciences and Practice, 2019 
 




 Design Sample 
Size 
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(U.S. region, age) 
Focus 
 












N = 21 East, AA adults at 
risk for hereditary 
breast cancer  
Explored barriers and 






Low knowledge level about GC 
and BRCA1/2, spiritual beliefs 
were described as a potential 
source of hope and coping, 
Motivators: help family members, 







N = 18   General population 
of AAW who 
participated in 
GC/GT 
Reviews included factors 
influencing GT follow-up 







AAW reported interest in GC/GT 
does not translate into actual 
GC/GT engagement, low GT 
knowledge level, 
spirituality associated with 
increased uptake, pretest 
counseling reduced cancer worry 
and greater decision satisfaction, 
GC that incorporates beliefs, 
reported less worries 
1 A 
Sussner 
et al39  
Cross-
sectional 
N = 146  East, AA adults at 




Examines the relationship 
of acculturation and breast 
cancer distress with 






Foreign born associated with 
negative emotional reactions about 
GT, breast cancer distress scores 
were positively associated with 
negative emotional reactions  
3 A 
Sussner 
et al40  
Cross-
sectional  






at increased risk for 
hereditary breast-
ovarian cancer 
Explored ethnic, racial, 
and cultural identity 
factors associated with GT 
follow-up 







Strong sense of ethnic identity 
related to having more positive 
beliefs and attitudes about GT, 
high ethnic search and racial 
identity scores associated with 
decrease uptake of GC/GT 
4 A 
Susswein 




N = 768  
 
South, AAW and 
WW who received 
GC  
Assessed BRCA1/2 GT 
uptake in recent 






More WW pursued GT than AAW, 
AAW recently diagnosed had a 
higher odd of progressing to GT 
than longer survivors 
4 A 
 
 
